Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential Effect of Orexin-1 and CRF-1 Antagonism on Stress Circuits: a fMRI Study in the Rat with the Pharmacological Stressor Yohimbine
Alessandro Gozzi, Stefano Lepore, Elena Vicentini, et al.
Neuropsychopharmacology (2013) Vol. 38, Iss. 11, pp. 2120-2130
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Distributed BOLD and CBV-weighted resting-state networks in the mouse brain
Francesco Sforazzini, Adam J. Schwarz, Alberto Galbusera, et al.
NeuroImage (2013) Vol. 87, pp. 403-415
Closed Access | Times Cited: 210
Orexin/hypocretin role in reward: implications for opioid and other addictions
Corey Baimel, Selena E. Bartlett, Lih‐Chu Chiou, et al.
British Journal of Pharmacology (2014) Vol. 172, Iss. 2, pp. 334-348
Open Access | Times Cited: 168
Stress and alcohol interactions: animal studies and clinical significance
Rainer Spanagel, Hamid R. Noori, Markus Heilig
Trends in Neurosciences (2014) Vol. 37, Iss. 4, pp. 219-227
Closed Access | Times Cited: 158
Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders
Morgan H. James, Erin J. Campbell, Christopher V. Dayas
Current topics in behavioral neurosciences (2017), pp. 197-219
Open Access | Times Cited: 102
Chemogenetic stimulation of tonic locus coeruleus activity strengthens the default mode network
Esteban A. Oyarzabal, Li‐Ming Hsu, Manasmita Das, et al.
Science Advances (2022) Vol. 8, Iss. 17
Open Access | Times Cited: 65
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Jiann Wei Yeoh, Erin J. Campbell, Morgan H. James, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 86
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice
Marta Squillace, Luca Dodero, Massimo Federici, et al.
Translational Psychiatry (2014) Vol. 4, Iss. 8, pp. e427-e427
Open Access | Times Cited: 67
The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice
Marcelo F. Lopez, David E. Moorman, Gary Aston‐Jones, et al.
Brain Research (2016) Vol. 1636, pp. 74-80
Open Access | Times Cited: 66
Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats
Robyn M. Brown, Andrezza K. Kim, Shaun Yon‐Seng Khoo, et al.
Addiction Biology (2015) Vol. 21, Iss. 3, pp. 603-612
Open Access | Times Cited: 64
Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy
Cliff H. Summers, Jazmine D. W. Yaeger, Clarissa D. Staton, et al.
Brain Research (2018) Vol. 1731, pp. 146085-146085
Open Access | Times Cited: 59
Cyclic tailor-made amino acids in the design of modern pharmaceuticals
Jiang Liu, Jianlin Han, Kunisuke Izawa, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112736-112736
Closed Access | Times Cited: 57
Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
Emilio Merlo Pich, Sergio Melotto
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 57
Orexin 2 receptor regulation of the hypothalamic–pituitary–adrenal (HPA) response to acute and repeated stress
Laura A. Grafe, Darrell Eacret, Sandra Luz, et al.
Neuroscience (2017) Vol. 348, pp. 313-323
Open Access | Times Cited: 50
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation
Pascal Bonaventure, Christine Dugovic, Brock T. Shireman, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 42
Efficacy, safety, and tolerability of JNJ-61393215 (tebideutorexant), a selective orexin-1 receptor antagonist, as adjunctive treatment for major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomized phase 2a study
Mark E. Schmidt, John A. Moyer, Iva Kezic, et al.
European Neuropsychopharmacology (2025) Vol. 95, pp. 14-23
Closed Access
Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies
Hiroshi Nagase, Naoshi Yamamoto, Masahiro Yata, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1018-1040
Closed Access | Times Cited: 34
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory
Darrell Eacret, Laura A. Grafe, Jane Dobkin, et al.
Behavioural Brain Research (2018) Vol. 356, pp. 444-452
Closed Access | Times Cited: 28
Orexin and Alzheimer’s Disease: A New Perspective
Yoo Hyun Um, Hyun Kook Lim
Psychiatry Investigation (2020) Vol. 17, Iss. 7, pp. 621-626
Open Access | Times Cited: 25
Corticotropin-releasing factor 1 receptor mediates the activity of the reward system evoked by morphine-induced conditioned place preference
M. Carmen Lasheras, M. Luisa Laorden, M. Victoria Milanés, et al.
Neuropharmacology (2014) Vol. 95, pp. 168-180
Closed Access | Times Cited: 28
Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in Mice
Sujin Yun, Michelle Wennerholm, Jonathan Shelton, et al.
Frontiers in Behavioral Neuroscience (2017) Vol. 11
Open Access | Times Cited: 23
Pharmacological investigations of a yohimbine–impulsivity interaction in rats
Megan K. Mahoney, John Barnes, David Wiercigroch, et al.
Behavioural Pharmacology (2016) Vol. 27, Iss. 7, pp. 585-595
Closed Access | Times Cited: 18
Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies
Dallece E. Curley, Talia R. Vasaturo-Kolodner, Nazzareno Cannella, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 12, pp. 2111-2122
Open Access | Times Cited: 9
Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity
Jazmine D. W. Yaeger, Kevin T. Krupp, Jason J. Gale, et al.
Medicine in Drug Discovery (2020) Vol. 8, pp. 100059-100059
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top